MedPath
HSA Approval

ASMAFEN SYRUP 1 mg/5 ml

SIN08831P

ASMAFEN SYRUP 1 mg/5 ml

ASMAFEN SYRUP 1 mg/5 ml

August 6, 1996

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AX17

ketotifen

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

KETOTIFEN HYDROGEN FUMARATE EQV KETOTIFEN

1 mg/5 ml

Ketotifen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ASMAFEN SYRUP 1 mg/5 ml - HSA Approval | MedPath